Target intelligence / Profile preview

Profilin 1 pseudogene 4 (PFN1P4)

Target
PFN1P4
Molecular classification
Other
01

Overview

Profilin 1 pseudogene 4 (PFN1P4) is a genomic DNA sequence classified as a pseudogene related to the actin-binding protein gene PFN1. PFN1P4 does not encode a functional protein and lacks established biological activity, disease roles, or relevance as a therapeutic target; its function, if any, is non-coding and undefined. Information about cellular function, disease association, drug interaction, and therapeutic mechanisms refers to the protein-coding PFN1 gene and its product, profilin-1—not to PFN1P4[6].

Other names
PFN1 pseudogene 4PFN1P4

Beyond the preview

Go deeper on Profilin 1 pseudogene 4 (PFN1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Profilin 1 pseudogene 4 (PFN1P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call